Fibronectin binding and proteolytic degradation by Leishmania and effects on macrophage activation

Manjusha M Kulkarni1, Eric A Jones, W Robert McMaster

  • 1Division of Infectious Diseases and Center for Microbial Interface Biology, The Ohio State University, Columbus, OH 43210, USA.

Infection and Immunity
|January 24, 2008
PubMed

Insights

Leishmania parasites bind to and degrade fibronectin (FN), a skin protein, using proteases. This degradation impacts macrophage responses and parasite infection within macrophages.

Area of Science:

  • Parasitology
  • Immunology
  • Molecular Biology

Background:

  • Leishmania parasites infect mammalian hosts via skin deposition.
  • Parasite interaction with extracellular matrix proteins like fibronectin (FN) may enhance invasion.
  • Previous studies suggested a role for FN in Leishmania invasion.

Purpose of the Study:

  • To investigate the direct binding of Leishmania parasites to FN and laminin (LM).
  • To identify parasite surface proteins involved in FN and LM binding.
  • To determine the role of parasite proteases in FN degradation and its impact on host cells.

Main Methods:

  • Binding assays using soluble FN and LM with Leishmania promastigotes and amastigotes.
  • Identification of parasite surface proteins via Western blot and immunoprecipitation.
  • Protease activity assays to assess FN degradation by leishmanolysin and cysteine protease B.
  • Measurement of reactive oxygen intermediates (ROIs) in infected macrophages.

Main Results:

  • Both Leishmania promastigotes and amastigotes bind directly to soluble FN and LM.
  • Promastigotes possess a ~60 kDa surface protein that binds FN and LM.
  • Leishmania promastigotes degrade FN using surface and secreted metalloprotease (leishmanolysin).
  • Leishmanolysin and cysteine protease B contribute to extracellular FN degradation.
  • Degraded FN reduced ROI production by infected macrophages and affected parasite accumulation.

Conclusions:

  • Leishmania parasites, in both life stages, bind to and proteolytically degrade FN.
  • Degradation occurs both at the parasite surface and extracellularly via secreted proteases.
  • Degraded FN influences the activation state of parasite-infected macrophages, potentially aiding parasite survival.

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Fibronectins Connect Cells with ECM01:25

Fibronectins Connect Cells with ECM

Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...